Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Receivables (2016 - 2025)

Historic Receivables for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $2.7 million.

  • Nephros' Receivables rose 5736.25% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 5736.25%. This contributed to the annual value of $1.8 million for FY2024, which is 1905.08% up from last year.
  • Nephros' Receivables amounted to $2.7 million in Q3 2025, which was up 5736.25% from $2.0 million recorded in Q2 2025.
  • Nephros' Receivables' 5-year high stood at $2.7 million during Q1 2025, with a 5-year trough of $1.3 million in Q4 2022.
  • Moreover, its 5-year median value for Receivables was $1.6 million (2021), whereas its average is $1.7 million.
  • Per our database at Business Quant, Nephros' Receivables tumbled by 2593.98% in 2023 and then skyrocketed by 7635.05% in 2025.
  • Nephros' Receivables (Quarter) stood at $1.6 million in 2021, then fell by 21.63% to $1.3 million in 2022, then rose by 16.33% to $1.5 million in 2023, then increased by 19.05% to $1.8 million in 2024, then skyrocketed by 49.41% to $2.7 million in 2025.
  • Its Receivables stands at $2.7 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.7 million for Q1 2025.